These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26511929)

  • 1. Intestinal decolonization of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature.
    Rieg S; Küpper MF; de With K; Serr A; Bohnert JA; Kern WV
    BMC Infect Dis; 2015 Oct; 15():475. PubMed ID: 26511929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.
    Huttner B; Haustein T; Uçkay I; Renzi G; Stewardson A; Schaerrer D; Agostinho A; Andremont A; Schrenzel J; Pittet D; Harbarth S
    J Antimicrob Chemother; 2013 Oct; 68(10):2375-82. PubMed ID: 23719234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.
    Bar-Yoseph H; Hussein K; Braun E; Paul M
    J Antimicrob Chemother; 2016 Oct; 71(10):2729-39. PubMed ID: 27317444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial.
    Huttner BD; de Lastours V; Wassenberg M; Maharshak N; Mauris A; Galperine T; Zanichelli V; Kapel N; Bellanger A; Olearo F; Duval X; Armand-Lefevre L; Carmeli Y; Bonten M; Fantin B; Harbarth S;
    Clin Microbiol Infect; 2019 Jul; 25(7):830-838. PubMed ID: 30616014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics for intestinal decolonization of ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled clinical trial.
    Ljungquist O; Kampmann C; Resman F; Riesbeck K; Tham J
    Clin Microbiol Infect; 2020 Apr; 26(4):456-462. PubMed ID: 31494254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral decontamination with colistin plus neomycin in solid organ transplant recipients colonized by multidrug-resistant Enterobacterales: a multicentre, randomized, controlled, open-label, parallel-group clinical trial.
    Fariñas MC; González-Rico C; Fernández-Martínez M; Fortún J; Escudero-Sanchez R; Moreno A; Bodro M; Muñoz P; Valerio M; Montejo M; Nieto J; Ruiz-San Millan JC; Casafont-Morencos F; Martinez-Martínez L; Fariñas-Álvarez C;
    Clin Microbiol Infect; 2021 Jun; 27(6):856-863. PubMed ID: 33359562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decolonization strategies for ESBL-producing or carbapenem-resistant Enterobacterales carriage: a systematic review and meta-analysis.
    Zhang HJ; Wang HW; Tian FY; Yang CZ; Zhao M; Ding YX; Wang XY; Cui XY
    Sci Rep; 2024 Oct; 14(1):24349. PubMed ID: 39420082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for the eradication of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae intestinal carriage.
    Catho G; Huttner BD
    Expert Rev Anti Infect Ther; 2019 Aug; 17(8):557-569. PubMed ID: 31313610
    [No Abstract]   [Full Text] [Related]  

  • 9. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns.
    Strenger V; Gschliesser T; Grisold A; Zarfel G; Feierl G; Masoud L; Hoenigl M; Resch B; Müller W; Urlesberger B
    Int J Antimicrob Agents; 2011 Jan; 37(1):67-9. PubMed ID: 21074372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation.
    Tschudin-Sutter S; Frei R; Dangel M; Stranden A; Widmer AF
    Clin Infect Dis; 2012 Dec; 55(11):1505-11. PubMed ID: 22955436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Gastrointestinal Colonization Rate with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia.
    Desta K; Woldeamanuel Y; Azazh A; Mohammod H; Desalegn D; Shimelis D; Gulilat D; Lamisso B; Makonnen E; Worku A; Mannerqvist K; Struwe J; Aspevall O; Aklillu E
    PLoS One; 2016; 11(8):e0161685. PubMed ID: 27574974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
    Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
    J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective multicentre study of rectal carriage of multidrug-resistant Enterobacteriaceae among health-care workers in Spain.
    Fernández-Verdugo A; Forcelledo L; Rodríguez-Lozano J; Rodríguez-Lucas C; Barreiro-Hurlé L; Canut A; de la Iglesia P; Escudero D; Calvo J; Boga JA; Margolles M; Rodicio MR; Fernández J
    Clin Microbiol Infect; 2020 May; 26(5):649.e1-649.e4. PubMed ID: 31972320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures.
    Dickstein Y; Geffen Y; Andreassen S; Leibovici L; Paul M
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4717-21. PubMed ID: 27216064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition of the intestinal microbiota in extended-spectrum β-lactamase-producing Enterobacteriaceae carriers and non-carriers in Thailand.
    Piewngam P; Quiñones M; Thirakittiwatthana W; Yungyuen T; Otto M; Kiratisin P
    Int J Antimicrob Agents; 2019 Apr; 53(4):435-441. PubMed ID: 30578963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
    Birgand G; Armand-Lefevre L; Lolom I; Ruppe E; Andremont A; Lucet JC
    Am J Infect Control; 2013 May; 41(5):443-7. PubMed ID: 22998785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
    Stupica D; Lusa L; Klevišar MN; Terzić S; Pirš M; Premru MM; Strle F
    Int J Antimicrob Agents; 2017 Oct; 50(4):564-571. PubMed ID: 28711676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance.
    Niehus R; van Kleef E; Mo Y; Turlej-Rogacka A; Lammens C; Carmeli Y; Goossens H; Tacconelli E; Carevic B; Preotescu L; Malhotra-Kumar S; Cooper BS
    Elife; 2020 May; 9():. PubMed ID: 32379042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal intestinal colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae-a 5-year follow-up study.
    Nordberg V; Jonsson K; Giske CG; Iversen A; Aspevall O; Jonsson B; Camporeale A; Norman M; Navér L
    Clin Microbiol Infect; 2018 Sep; 24(9):1004-1009. PubMed ID: 29326011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.